Product Name: PKG1 (511-521) pT515+pT517
Product Number: PE-04ARO99
Size: 200 µg      Price:71.00
1 mg      $US142.00
5 mg      311.00
Peptide Name: PKG1 (511-521) pT515+pT517

Product Use: Services as a blocking peptide for use with the PKG1-pT515+pT517 rabbit polyclonal antibody (Cat. No.: AB-PK776) that is also available from Kinexus. This phosphopeptide may also be useful as a substrate for screening the phosphatase activity of protein phosphatases. The peptide sequence is located in the protein kinase catalytic domain activation T-loop between subdomains VII and VIII. T515 and T517 phosphorylation stimulates phosphotransferase activity.

Peptide Production Method: Solid-phase peptide synthesis

Peptide Origin: Homo sapiens

Peptide Sequence: FGKK-pT-W-pT-FCG

Peptide Modifications N Terminus: Free amino

Peptide Modifications C Terminus: βAla-Cys
Peptide Modifications Other: Phosphorylated

Peptide Molecular Mass Calculated: 1549.6 Da

Peptide Purity Percent after Synthesis and Purification: >95

Peptide Appearance: White powder

Peptide Form: Solid

Storage Conditions: -20°C

Related Product 1: PKG1 - pT515+pT517 phosphosite-specific antibody (Cat. No.: AB-PK776)

Scientific Background: PKG1 (PRKG1) is a protein-serine/threonine kinase of the AGC group and PKG family. It is activated by cGMP, which is generated in response to nitric oxide. Phosphorylation at T59 increases phosphotransferase activity and its affinity for cGMP Phosphorylation at T517 increases phosphotransferase activity. An R177Q mutation in AAT8 results in a constitutively active form of PKG1, which also has reduced cGMP binding.